Other · 2025
Interviews with terminally ill people before and after psilocybin-assisted therapy
- Original title
- Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally ill.
- Authors
- Dwyer J, Johnston RB, O'Callaghan C, et al.
- Journal
- General hospital psychiatry, 2025
- Molecules
- Psilocybin
- Conditions
- End-of-life distress, Anxiety
- Evidence grade
- Very low
- Source
- Read the original paper
The question
How does psilocybin-assisted psychotherapy change the way terminally ill people with severe death anxiety experience their daily lives?
What they did
Researchers interviewed people with a terminal illness before and after they took part in a randomized controlled trial of psychedelic-assisted psychotherapy in Australia. The interviews were analyzed using interpretative phenomenological analysis, a method that looks closely at how people describe and make sense of their own experiences. The aim was to describe personal change in the participants’ own words, not to measure symptom scores.
What they found
Before treatment, participants described feeling displaced from their own lives: frightened, alone, and stuck in an overwhelming present dominated by the nearness of death. After treatment, those who did well described being able to inhabit their lives more fully, with a richer and more joyful sense of the present, even while facing death. The authors conclude that the psilocybin session itself was necessary but not sufficient for this shift, with the surrounding psychotherapy also playing a part. The abstract reports no numbers, doses, or symptom-rating results.
The fine print
This is a qualitative study: it describes experiences rather than measuring whether the treatment works, and the abstract does not state how many people were interviewed. Interviews were with participants from a single trial, and the analysis focused on those for whom treatment was considered successful, which may leave out people who did not benefit or who were harmed. Interpretation of interview material depends on the researchers’ judgment. This summary is based on the abstract alone.
What it means
The study offers a detailed account of what improvement can look like for terminally ill people with intense death anxiety, and suggests the therapy surrounding a psilocybin session matters as much as the drug itself. It cannot tell us how often such change occurs or how long it lasts.
Evidence grade: Very low. A qualitative interview sub-study attached to a randomized trial, with no sample size or measured outcomes reported in the abstract.
This summary is based on the study’s published abstract.